References

  1. Seely AJ, Naud JF, Campisi G, et al. Alteration of chemoattractant receptor expression regulates human neutrophil chemotaxis in vivo. Ann Surg. 2002;235(4):550-559.
  2. Seely AJ, Swartz DE, Giannias B, Christou NV. Reduction in neutrophil cell surface expression of tumor necrosis factor receptors but not Fas after transmigration: implications for the regulation of neutrophil apoptosis. Arch Surg. 1998;133(12):1305-1310.
  3. Seely AJ, Pascual JL, Christou NV. Science review: Cell membrane expression (connectivity) regulates neutrophil delivery, function and clearance. Critical care (London, England). 2003;7(4):291-307.
  4. Gallagher R, Appenzeller T. Beyond Reductionism. Science. 1999;284:79.
  5. Seely AJ, Christou NV. Multiple organ dysfunction syndrome: exploring the paradigm of complex nonlinear systems. Critical Care Medicine. 2000;28(7):2193-2200.
  6. Seely AJ, Macklem PT. Complex systems and the technology of variability analysis. Critical care (London, England). 2004;8(6):R367–R384-R367–R384.
  7. Berkenbosch F, van Oers J, del Rey A, Tilders F, Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science. 1987;238(4826):524-526.
  8. Sanders VM, Powell-Oliver FE. Beta 2-adrenoceptor stimulation increases the number of antigen-specific precursor B lymphocytes that differentiate into IgM-secreting cells without affecting burst size. J Immunol. 1992;148(6):1822-1828.
  9. Ader R, Cohen N, Felten D. Psychoneuroimmunology: interactions between the nervous system and the immune system. Lancet. 1995;345(8942):99-103.
  10. Standardization of spirometry–1987 update:statement of the American Thoracic Society. Am Rev Respir Dis 1987;136:1285–1298.
  11. Guilbert B, Dighiero G, Avrameas S. Naturally occurring antibodies against nine common antigens in human sera. I. Detection, isolation and characterization. J Immunol. 1982;128(6):2779-2787.
  12. Pfueller SL, Logan D, Tran TT, Bilston RA. Naturally occurring human IgG antibodies to intracellular and cytoskeletal components of human platelets. Clin Exp Immunol. 1990;79(3):367-373.
  13. Lacroix-Desmazes S, Mouthon L, Coutinho A, Kazatchkine MD. Analysis of the natural human IgG antibody repertoire: life-long stability of reactivities towards self antigens contrasts with age-dependent diversification of reactivities against bacterial antigens. Eur J Immunol. 1995;25(9):2598-2604.
  14. Dinarello CA. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest. 1997;112(6 Suppl):321S-329S.
  15. van der Poll T, van Deventer SJ, Hack CE, et al. Effects on leukocytes after injection of tumor necrosis factor into healthy humans. Blood. 1992;79(3):693-698.
  16. Friedland JS, Porter JC, Daryanani S, et al. Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit. Crit Care Med. 1996;24(11):1775-1781.
  17. Glass L MM. From Clocks to Chaos: The Rhythms of Life. Princeton: Princeton University Press; 1988.
  18. Garrard CS, Kontoyannis DA, Piepoli M. Spectral analysis of heart rate variability in the sepsis syndrome. Clin Auton Res. 1993;3(1):5-13.
  19. Korach M, Sharshar T, Jarrin I, et al. Cardiac variability in critically ill adults: influence of sepsis. Crit Care Med. 2001;29(7):1380-1385.
  20. Barnaby D, Ferrick K, Kaplan DT, Shah S, Bijur P, Gallagher EJ. Heart rate variability in emergency department patients with sepsis. Acad Emerg Med. 2002;9(7):661-670.
  21. Annane D, Trabold F, Sharshar T, et al. Inappropriate sympathetic activation at onset of septic shock: a spectral analysis approach. American journal of respiratory and critical care medicine. 1999;160(2):458-465.
  22. Piepoli M, Garrard CS, Kontoyannis DA, Bernardi L. Autonomic control of the heart and peripheral vessels in human septic shock. Intensive Care Medicine. 1995;21(2):112-119.
  23. Ahmad S, Ramsay T, Huebsch L, et al. Continuous multi-parameter heart rate variability analysis heralds onset of sepsis in adults. PLoS ONE. 2009;4(8):e6642.
  24. Bravi A, Green G, Longtin A, Seely AJ. Monitoring and identification of sepsis development through a composite measure of heart rate variability. PLoS One. 2012;7(9):e45666.
  25. Pontet J, Contreras P, Curbelo A, et al. Heart rate variability as early marker of multiple organ dysfunction syndrome in septic patients. J Crit Care. 2003;18(3):156-163.
  26. Chen W-L, Chen J-H, Huang C-C, Kuo C-D, Huang C-I, Lee L-S. Heart rate variability measures as predictors of in-hospital mortality in ED patients with sepsis. The American Journal of Emergency Medicine. 2008;26(4):395-401.
  27. Green GC, Bradley B, Bravi A, Seely AJ. Continuous multiorgan variability analysis to track severity of organ failure in critically ill patients. J Crit Care. 2013;28(5):879 e871-811.
  28. Brack T, Jubran A, Tobin MJ. Dyspnea and decreased variability of breathing in patients with restrictive lung disease. American journal of respiratory and critical care medicine. 2002;165(9):1260-1264.
  29. Papaioannou VE, Chouvarda I, Maglaveras N, Dragoumanis C, Pneumatikos I. Changes of heart and respiratory rate dynamics during weaning from mechanical ventilation: a study of physiologic complexity in surgical critically ill patients. J Crit Care. 2011;26(3):262-272.
  30. Savi A, Teixeira C, Silva JM, et al. Weaning predictors do not predict extubation failure in simple-to-wean patients. J Crit Care. 2012;27(2):221 e221-228.
  31. Papaioannou VE, Chouvarda IG, Maglaveras NK, Pneumatikos IA. Study of multiparameter respiratory pattern complexity in surgical critically ill patients during weaning trials. BMC Physiol. 2011;11:2.
  32. Segal LN, Oei E, Oppenheimer BW, et al. Evolution of pattern of breathing during a spontaneous breathing trial predicts successful extubation. Intensive Care Med. 2010;36(3):487-495.
  33. Seely AJ, Bravi A, Herry C, et al. Do heart and respiratory rate variability improve prediction of extubation outcomes in critically ill patients? Critical care (London, England). 2014;18(2):R65.
  34. Goldberger AL, Peng CK, Lipsitz LA. What is physiologic complexity and how does it change with aging and disease? Neurobiol Aging. 2002;23(1):23-26.
  35. Bravi A, Longtin A, Seely AJ. Review and classification of variability analysis techniques with clinical applications. Biomed Eng Online. 2011;10:90.
  36. Bravi A, Herry C, Townsend D, et al. Towards the identification of independent measures of heart rate variability Journal of Critical Care 2013;28:e16-e16.
  37. Seely AJ, Macklem PT. Complex systems and the technology of variability analysis. Critical care (London, England). 2004;8(6):R367-384.
  38. Goldberger AL. Non-linear dynamics for clinicians: chaos theory, fractals, and complexity at the bedside. Lancet. 1996;347(9011):1312-1314.
  39. Ahmad S, Tejuja A, Newman KD, Zarychanski R, Seely AJ. Clinical review: a review and analysis of heart rate variability and the diagnosis and prognosis of infection. Critical care (London, England). 2009;13(6):232.
  40. Bravi A, Green G, Herry C, et al. Do physiological and pathological stresses produce different changes in heart rate variability? Front Physiol. 2013;4:197.
  41. Herry CL, Green GC, Bravi A, Seely AJE. Continuous Multiorgan Variability Monitoring in Critically Ill Patients: Complexity Science at the Bedside. New York: Springer; 2013.
  42. Seely AJ. Heart rate variability and infection: diagnosis, prognosis, and prediction. J Crit Care. 2006;21(3):286-289.
  43. Seely AJ. Complexity at the bedside. J Crit Care. 2011;26(3):323-324.
  44. Barnaby DP, Fernando SM, Herry CL, Scales NB, Gallagher EJ, Seely AJE. Heart Rate Variability, Clinical and Laboratory Measures to Predict Future Deterioration
    in Patients Presenting with Sepsis. Shock. 2018.
  45. Seely AJ. Embracing the certainty of uncertainty: implications for health care and research. Perspect Biol Med. 2013;56(1):65-77.
  46. Seely AJ. Prediction Is Difficult, Especially About Future Unexpected Deterioration. Crit Care Med. 2016;44(9):1781-1783.
  47. Yu JB, Soulos PR, Cramer LD, Decker RH, Kim AW, Gross CP. Comparative effectiveness of surgery and radiosurgery for stage I non-small cell lung cancer. Cancer. 2015;121(14):2341-2349.
  48. Chen FF, Zhang D, Wang YL, Xiong B. Video-assisted thoracoscopic surgery lobectomy versus open lobectomy in patients with clinical stage non-small cell lung cancer: a meta-analysis. Eur J Surg Oncol. 2013;39(9):957-963.
  49. Ivanovic J, Seely A, Anstee C, et al. Measuring surgical quality: A comparison of postoperative adverse events with the American College of Surgeons National Surgical Quality Improvement Program and the Thoracic Morbidity and Mortality System. J Am Coll Surg. Submitted September 2013.
  50. Phillips JD, Merkow RP, Sherman KL, DeCamp MM, Bentrem DJ, Bilimoria KY. Factors affecting selection of operative approach and subsequent short-term outcomes after anatomic resection for lung cancer. J Am Coll Surg. 2012;215(2):206-215.
  51. Seely AJ, Ivanovic J, Threader J, et al. Systematic classification of morbidity and mortality after thoracic surgery. The Annals of thoracic surgery. 2010;90(3):936-942; discussion 942.
  52. Andalib A, Ramana-Kumar AV, Bartlett G, Franco EL, Ferri LE. Influence of postoperative infectious complications on long-term survival of lung cancer patients: a population-based cohort study. J Thorac Oncol. 2013;8(5):554-561.
  53. Khuri SF, Henderson WG, DePalma RG, et al. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg. 2005;242(3):326-341; discussion 341-323.
  54. Khan NA, Quan H, Bugar JM, Lemaire JB, Brant R, Ghali WA. Association of postoperative complications with hospital costs and length of stay in a tertiary care center. J Gen Intern Med. 2006;21(2):177-180.
  55. Irshad K, Feldman LS, Chu VF, Dorval JF, Baslaim G, Morin JE. Causes of increased length of hospitalization on a general thoracic surgery service: a prospective observational study. Can J Surg. 2002;45(4):264-268.
  56. Freeman RK, Dilts JR, Ascioti AJ, Dake M, Mahidhara RS. A comparison of length of stay, readmission rate, and facility reimbursement after lobectomy of the lung. The Annals of thoracic surgery. 2013;96(5):1740-1745; discussion 1745-1746.
  57. Harrison R, Walton M, Manias E, et al. The missing evidence: a systematic review of patients’ experiences of adverse events in health care. Int J Qual Health Care. 2015;27(6):424-442.
  58. Vonlanthen R, Slankamenac K, Breitenstein S, et al. The impact of complications on costs of major surgical procedures: a cost analysis of 1200 patients. Ann Surg. 2011;254(6):907-913.
  59. Baker GR, Norton PG, Flintoft V, et al. The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ. 2004;170(11):1678-1686.
  60. Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med. 1991;324(6):370-376.
  61. Backman C, Vanderloo S, Forster AJ. Measuring and improving quality in university hospitals in Canada: The Collaborative for Excellence in Healthcare Quality. Health Policy. 2016;120(9):982-986.
  62. Miller JD, Jain MK, de Gara CJ, Morgan D, Urschel JD. Effect of surgical experience on results of esophagectomy for esophageal carcinoma. J Surg Oncol. 1997;65(1):20-21.
  63. Iyer AKV, Yadav S. Postoperative care and complications after thoracic surgery. In: Firstenberg MS, ed. Principles and Practice of Cardiothoracic Surgery 2013.
  64. Finley CJ, Schneider L, Shakeel S. Approaches to high-risk, resource intensive cancer surgical care in Canada. 2019.
  65. Finley CJ, Bendzsak A, Tomlinson G, Keshavjee S, Urbach DR, Darling GE. The effect of regionalization on outcome in pulmonary lobectomy: a Canadian national study. J Thorac Cardiovasc Surg. 2010;140(4):757-763.
  66. Finley CJ, Jacks L, Keshavjee S, Darling G. The effect of regionalization on outcome in esophagectomy: a Canadian national study. The Annals of thoracic surgery. 2011;92(2):485-490; discussion 490.
  67. Ivanovic J, Al-Hussaini A, Al-Shehab D, et al. Evaluating the reliability and reproducibility of the Ottawa Thoracic Morbidity and Mortality classification system. The Annals of thoracic surgery. 2011;91(2):387-393.
  68. Ivanovic J, Seely AJ, Anstee C, et al. Measuring surgical quality: comparison of postoperative adverse events with the american college of surgeons NSQIP and the Thoracic Morbidity and Mortality classification system. J Am Coll Surg. 2014;218(5):1024-1031.
  69. Ivanovic J, Maziak DE, Ramzan S, et al. Incidence, severity and perioperative risk factors for atrial fibrillation following pulmonary resection. Interact Cardiovasc Thorac Surg. 2014;18(3):340-346.
  70. Liang S, Ivanovic J, Gilbert S, et al. Quantifying the incidence and impact of postoperative prolonged alveolar air leak after pulmonary resection. J Thorac Cardiovasc Surg. 2013;145(4):948-954.
  71. Salati M, Pompili C, Refai M, Xiume F, Sabbatini A, Brunelli A. The use of the Thoracic Morbidity and Mortality system for the internal analysis of performance: a case-matched temporal audit. Eur J Cardiothorac Surg. 2014;45(5):859-863.
  72. Salati M, Refai M, Pompili C, Xiume F, Sabbatini A, Brunelli A. Major morbidity after lung resection: a comparison between the European Society of Thoracic Surgeons Database system and the Thoracic Morbidity and Mortality system. J Thorac Dis. 2013;5(3):217-222.
  73. Smoyer WE, Embi PJ, Moffatt-Bruce S. Creating Local Learning Health Systems: Think Globally, Act Locally. JAMA. 2016;316(23):2481-2482.
  74. Houghton C, Meskell P, Delaney H, et al. Barriers and facilitators to healthcare workers’ adherence with infection prevention and control (IPC) guidelines for respiratory infectious diseases: a rapid qualitative evidence synthesis. Cochrane Database Syst Rev. 2020;4:CD013582.
  75. Ip VHY, Sondekoppam RV, Ozelsel TJP, Tsui BCH. COVID-19 Pandemic: International Variation of Personal Protective Equipment and Infection Prevention and Control Guidelines. Anesth Analg. 2020;131(2):e113-e114.
  76. University of Oxford. Randomised Evaluation of COVID-19 Therapy. https://clinicaltrials.gov/ct2/show/NCT04381936. Published 2020. Accessed.
  77. Ivanovic J, Anstee C, Ramsay T, et al. Using Surgeon-Specific Outcome Reports and Positive Deviance for Continuous Quality Improvement. The Annals of thoracic surgery. 2015;100(4):1188-1194; discussion 1194-1185.
  78. Ivanovic J, Mostofian F, Anstee C, et al. Impact of Surgeon Self-evaluation and Positive Deviance on Postoperative Adverse Events After Non-cardiac Thoracic Surgery. J Healthc Qual. 2018;40(4):e62-e70.
  79. Kleidon A, Malhi Y, Cox PM. Maximum entropy production in environmental and ecological systems. Philos Trans R Soc Lond B Biol Sci. 2010;365(1545):1297-1302.
  80. Niven RK. Steady state of a dissipative flow-controlled system and the maximum entropy production principle. Phys Rev E Stat Nonlin Soft Matter Phys. 2009;80(2 Pt 1):021113.
  81. Boser SR, Park H, Perry SF, Menache MG, Green FH. Fractal geometry of airway remodeling in human asthma. American journal of respiratory and critical care medicine. 2005;172(7):817-823.
  82. Gupta S, Hartley R, Khan UT, et al. Quantitative computed tomography-derived clusters: redefining airway remodeling in asthmatic patients. J Allergy Clin Immunol. 2014;133(3):729-738 e718.
  83. Doubal FN, MacGillivray TJ, Patton N, Dhillon B, Dennis MS, Wardlaw JM. Fractal analysis of retinal vessels suggests that a distinct vasculopathy causes lacunar stroke. Neurology. 2010;74(14):1102-1107.
  84. Cavallari M, Falco T, Frontali M, Romano S, Bagnato F, Orzi F. Fractal analysis reveals reduced complexity of retinal vessels in CADASIL. PLoS One. 2011;6(4):e19150.
  85. Seely A, Newman KD, Herry C. Fractal Structure and Entropy Production within the Central Nervous System. Entropy. 2014;16(8): 4497-4520.
  86. Costa M, Goldberger AL, Peng CK. Multiscale entropy analysis of complex physiologic time series. Phys Rev Lett. 2002;89(6):068102.
  87. Goldberger AL, Amaral LA, Glass L, et al. PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals. Circulation. 2000;101(23):E215-220.
  88. Axelrod S, Lishner M, Oz O, Bernheim J, Ravid M. Spectral analysis of fluctuations in heart rate: an objective evaluation of autonomic nervous control in chronic renal failure. Nephron. 1987;45(3):202-206.
  89. van de Borne P, Montano N, Pagani M, Oren R, Somers VK. Absence of low-frequency variability of sympathetic nerve activity in severe heart failure. Circulation. 1997;95(6):1449-1454.
  90. Bonaduce D, Petretta M, Marciano F, et al. Independent and incremental prognostic value of heart rate variability in patients with chronic heart failure. Am Heart J. 1999;138(2 Pt 1):273-284.
  91. Guzzetti S, Mezzetti S, Magatelli R, et al. Linear and non-linear 24 h heart rate variability in chronic heart failure. Auton Neurosci. 2000;86(1-2):114-119.
  92. Huang J, Sopher SM, Leatham E, Redwood S, Camm AJ, Kaski JC. Heart rate variability depression in patients with unstable angina. Am Heart J. 1995;130(4):772-779.
  93. Lishner M, Akselrod S, Avi VM, Oz O, Divon M, Ravid M. Spectral analysis of heart rate fluctuations. A non-invasive, sensitive method for the early diagnosis of autonomic neuropathy in diabetes mellitus. Journal of the autonomic nervous system. 1987;19(2):119-125.
  94. Mussalo H, Vanninen E, Ikaheimo R, et al. Heart rate variability and its determinants in patients with severe or mild essential hypertension. Clin Physiol. 2001;21(5):594-604.
  95. Poulsen SH, Jensen SE, Moller JE, Egstrup K. Prognostic value of left ventricular diastolic function and association with heart rate variability after a first acute myocardial infarction. Heart (British Cardiac Society). 2001;86(4):376-380.
  96. Odemuyiwa O, Malik M, Farrell T, Bashir Y, Poloniecki J, Camm J. Comparison of the predictive characteristics of heart rate variability index and left ventricular ejection fraction for all-cause mortality, arrhythmic events and sudden death after acute myocardial infarction. The American journal of cardiology. 1991;68(5):434-439.
  97. van Boven AJ, Jukema JW, Haaksma J, Zwinderman AH, Crijns HJ, Lie KI. Depressed heart rate variability is associated with events in patients with stable coronary artery disease and preserved left ventricular function. REGRESS Study Group. Am Heart J. 1998;135(4):571-576.
  98. Buchan CA, Bravi A, Seely AJ. Variability Analysis and the Diagnosis, Management, and Treatment of Sepsis. Curr Infect Dis Rep. 2012.
  99. Schols AM, Fredrix EW, Soeters PB, Westerterp KR, Wouters EF. Resting energy expenditure in patients with chronic obstructive pulmonary disease. Am J Clin Nutr. 1991;54(6):983-987.
  100. Frankenfield DC, Wiles CE, 3rd, Bagley S, Siegel JH. Relationships between resting and total energy expenditure in injured and septic patients. Crit Care Med. 1994;22(11):1796-1804.
  101. Kouparris LS. Harmless herbs: A cause for concern? Anaesthesia. 2002;55:86-103.
Close Bitnami banner
Bitnami